All Posts: News Release
-
New Understanding of How to Harness the Immune System to Fight Cancer
Georgetown University’s Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, which are infection and tumor-fighting white blood cells, so that they have a superior memory, thereby making them more effective in killing cancer cells.
Category: News Release
-
Method Developed to Identify Best Treatment Combinations for Glioblastoma Based on Unique Cellular Targets
Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for treating glioblastoma, a lethal brain tumor. This approach enabled them to predict more effective treatment combinations to fight the disease on an individualized basis. This laboratory and computational research effort was led by scientists at Georgetown Lombardi.
Category: News Release
-
An Overlooked Hormone Eyed as Deadly Driver of Postmenopausal Breast Cancer in Women with Obesity
A new analysis of research into the most common type of breast cancer has zeroed in on an overlooked hormone that may be responsible for the increased risk of breast cancer death in postmenopausal women with obesity. It also raises the possibility that treatment of these aggressive breast cancers could be improved with the addition of weight-loss drugs known as GLP-1 receptor agonists.
Category: News Release
-
Leading Cancer Research Centers Reinforce Importance of Safe and Effective Human Papillomavirus (HPV) Vaccination To Prevent Cancer
National Cancer Institute (NCI)-Designated Cancer Centers with leading national organizations and the University of Puerto Rico Comprehensive Cancer Center have released a joint statement reinforcing the importance of safe and effective human papillomavirus (HPV) vaccination to prevent cancer. Nationally, HPV vaccination coverage has stagnated and falls short of the national goals.
Category: News Release
-
Clinical Study Deepens Understanding of Mesothelioma and Opens the Door to Potential Treatment Options
People with operable diffuse pleural mesothelioma may benefit from immunotherapy before and after surgery, based on results of a clinical trial exploring the sequence of treatment and the role of surgery for this difficult to treat cancer.
Category: News Release
-
Rate of Rare Liver Cancer High Among Russian Nuclear Workers, Particularly Women, Study Finds
A new study of Russian nuclear workers, one of only a few to examine liver cancer in people exposed to radiation in a chronic, low-dose occupational setting, finds higher rates of bile duct cancer and hepatocellular carcinoma among the workers, as well as unusually high rates in women of angiosarcoma of the liver, a form of cancer that is extremely rare.
Category: News Release
-
Georgetown Study Highlights Opportunities for Liver Cancer Interventions in Thailand
Safer pesticide practices, clean drinking water, and effective community health programs could help reduce liver and bile duct cancer risk in Thailand, according to a new study by researchers at Georgetown’s Lombardi Comprehensive Cancer Center.
Category: News Release
-
Hebrew University and Georgetown University’s Lombardi Comprehensive Cancer Center Establish Research Collaboration
Recognizing the power of education and research in preventing, treating and curing one of the world’s most deadly diseases, the Hebrew University of Jerusalem and Georgetown University have established a joint initiative on cancer to amplify innovation, discovery and action to end the disease.
Category: News Release
-
Rise in Claim Denial Rates for Cancer-Related Advanced Genetic Testing
A newly published analysis by Georgetown Lombardi member So-Yeon Kang, PhD, MBA, and colleagues has found that both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national coverage determination that established coverage standards for NGS testing. Read more about this research.
Category: News Release
-
Georgetown Lombardi Announces 2025 Gala Co-Chairs
Georgetown University’s Lombardi Comprehensive Cancer Center today announced that philanthropist and business executive Sherrie Beckstead and Emmy award-winning sportscaster and community advocate Wes Hall will serve as the 37th annual Lombardi Gala co-chairs.
Category: News Release